TETRAPHASE PHARMACEUTICALS INC
DelistedCIK 1373707fmd_1QGS758AXKVY1NEQ8QWTGJVB3WManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Mar 31, 2020, 39 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 8 | 10 | 9 | 12 | 5 | 10 | 19 | 7 |
| Research and development | – | 18 | 17 | 32 | 62 | 74 | 64 | 102 | 55 | 23 |
| Selling, general and administrative | – | – | – | – | – | – | – | 24 | 37 | 49 |
| Total operating expenses | – | – | – | – | – | – | – | 125 | 92 | 75 |
| Operating income | – | (21) | (14) | (28) | (66) | (83) | (78) | (116) | (73) | (68) |
| Interest expense | – | 0 | 1 | 2 | 1 | 0 | – | – | 1 | 3 |
| Interest and investment income | – | 0 | – | 0 | 0 | 0 | 0 | 1 | 2 | 1 |
| Other non-operating income (expense) | – | (0) | (1) | (1) | (1) | (0) | 0 | 1 | – | – |
| Income before taxes | – | – | – | (0) | (67) | (83) | (77) | (115) | (72) | (70) |
| Net income | (17) | (22) | (15) | (30) | (67) | (83) | (77) | (115) | (72) | (70) |